Source:http://linkedlifedata.com/resource/pubmed/id/17264160
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2007-5-1
|
pubmed:abstractText |
Benzene polyphosphates containing phosphate groups on one ring are Ins(1,4,5)P3 5-phosphatase inhibitors when evaluated against type-I Ins(1,4,5)P3 5-phosphatase. A novel biphenyl derivative, biphenyl 2,3',4,5',6-pentakisphosphate, with five phosphate groups on two rings was synthesized: It inhibited the activity of two inositol 5-phosphatases: type I and SHIP2 with Ins(1,3,4,5)P4 as substrate. The inhibition was competitive with respect to the substrate. IC50 value measured in rat hepatocytes, which contains the native Ins(1,4,5)P3 5-phosphatase, was in the micromolar range at 1.0 microM Ins(1,4,5)P3 as substrate. Biphenyl 2,3',4,5',6-pentakisphosphate did not affect the activity of Ins(1,4,5)P3 3-kinase A in the 5-100 microM range. Surprisingly, experimental evidence supports an effect of biphenyl 2,3',4,5',6-pentakisphosphate at the level of the Ins(1,4,5)P3 receptor. Finally, when injected into rat hepatocytes, the analog affected the frequency of Ca2+ oscillations in a positive or negative way depending on its concentration. At very high concentrations of the analog, Ca2+ oscillations were even suppressed. These data were interpreted as a dual effect of the biphenyl 2,3',4,5',6-pentakisphosphate on cytosolic [Ca2+] increases: an activation effect through an increase in Ins(1,4,5)P3 level via Ins(1,4,5)P3 5-phosphatase inhibition and an inhibitory effect, which was exerted directly on the Ins(1,4,5)P3 receptor. Thus, our data show for the first time that the frequency of Ca2+ oscillations in response to a Ca2+-mobilizing agonist can be controlled by inhibitors of type-I Ins(1,4,5)P3 5-phosphatase.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1530-6860
|
pubmed:author |
pubmed-author:BackersKatrienK,
pubmed-author:CombettesLaurentL,
pubmed-author:De SmedtHumbertH,
pubmed-author:DupontGenevièveG,
pubmed-author:ErneuxChristopheC,
pubmed-author:MillsStephen JSJ,
pubmed-author:MissiaenLudwigL,
pubmed-author:ParysJan BJB,
pubmed-author:PotterBarry V LBV,
pubmed-author:VandeputFabriceF,
pubmed-author:WohlkönigAlexandreA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1481-91
|
pubmed:dateRevised |
2007-8-13
|
pubmed:meshHeading |
pubmed-meshheading:17264160-Animals,
pubmed-meshheading:17264160-Biphenyl Compounds,
pubmed-meshheading:17264160-Calcium,
pubmed-meshheading:17264160-Cell Line,
pubmed-meshheading:17264160-Female,
pubmed-meshheading:17264160-Hepatocytes,
pubmed-meshheading:17264160-Microinjections,
pubmed-meshheading:17264160-Phosphates,
pubmed-meshheading:17264160-Rats,
pubmed-meshheading:17264160-Rats, Wistar,
pubmed-meshheading:17264160-Spodoptera
|
pubmed:year |
2007
|
pubmed:articleTitle |
Biphenyl 2,3',4,5',6-pentakisphosphate, a novel inositol polyphosphate surrogate, modulates Ca2+ responses in rat hepatocytes.
|
pubmed:affiliation |
Institut de Recherche Interdisciplinaire (IRIBHM), Université Libre de Bruxelles, Campus Erasme, 808 Route de Lennik, 1070 Brussels, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|